Dermata Therapeutics Inc.

NASDAQ: DRMA · Real-Time Price · USD
5.90
0.09 (1.55%)
At close: Aug 15, 2025, 3:59 PM
5.98
1.36%
After-hours: Aug 15, 2025, 04:00 PM EDT

Dermata Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
n/a n/a n/a n/a
Gross Profit
n/a n/a n/a n/a
Operating Income
-12.51M -8.04M -9.67M -7.86M
Interest Income
225.78K 247.22K 63.57K 45.61
Pretax Income
-12.29M -7.79M -9.61M -7.9M
Net Income
-12.29M -7.79M -9.61M -7.9M
Selling & General & Admin
4.31M 3.97M 4.02M 4.4M
Research & Development
8.2M 4.07M 5.65M 3.46M
Other Expenses
-242 n/a n/a n/a
Operating Expenses
12.51M 8.04M 9.67M 7.86M
Interest Expense
n/a n/a -63.57K 45.61K
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
12.51M 8.04M 9.67M 7.86M
Income Tax Expense
n/a n/a -9.67K n/a
Shares Outstanding (Basic)
153K 19.4K 69.07K 52.05K
Shares Outstanding (Diluted)
153K 19.5K 69.07K 52.05K
EPS (Basic)
-80.32 -401.8 -139.2 -152.7
EPS (Diluted)
-80.32 -399.81 -139.2 -152.7
EBITDA
-12.29M 247.22K -9.61M -7.86M
EBIT
-12.29M -7.79M -9.61M -7.86M
Depreciation & Amortization
12.51M 8.04M 9.67M 322.00